Kerentech

Kerentech is a company specializing in fundraising for Life Sciences companies operating in high-risk therapeutic areas, with a focus on experience ranging from $5M-$60M. The company's expertise lies in the search for investors for Life Sciences and Medtech companies, facilitating Outlicense, Joint Ventures, M&A, specific business development related to pharma, biotech, and medtech, as well as IP trade and negotiation. Based in Spain and Israel, Kerentech serves a global clientele, including the United States, United Kingdom, France, Israel, Spain, India, China, and Hong-Kong. Kerentech has minimal transaction requirements for Drug Development and Medtech, with experience spanning from start-ups and spin-offs to PIPE in Nasdaq quoted companies, phase III transactions. The company also specializes in fundraising for incubators, funds, and operations between funds focused on Life Sciences. With a team possessing more than 40 accumulated years of experience, Kerentech was founded in 2003. Overall, Kerentech presents an opportunity for investors to engage with a company that has a significant track record in fundraising and supporting innovative ventures within the Biotechnology and Health Care industries. For further information, interested parties can reach out to info (at) kerentech.com.